Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01994993 · ClinicalTrials.gov registry record · Phase 2
Antibiotic Safety (SCAMP)
A Phase 2 study, sponsored by Michael Cohen-Wolkowiez.
- Completed
- Registry status
- Phase 2
- Development phase
- 260
- Enrollment target
NCT01994993: Completed Phase 2 study, sponsored by Michael Cohen-Wolkowiez.
NCT01994993 is a Phase 2 study that has completed, run by Michael Cohen-Wolkowiez. The registered enrollment target is 260 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01994993, a Phase 2 study, has completed, sponsored by Michael Cohen-Wolkowiez.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 260 participants
- Enrollment target
Study Summary
The main purpose of this study is evaluate whether it is safe or not to use various combination of antibiotics (ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, gentamicin) in treating infants with complicated intra-abdominal infections
Primary Outcome
Number of Participants who experienced Death
Interventions
- DRUG ampicillin and metronidazole and gentamicin
- DRUG ampicillin and gentamicin and clindamycin
- DRUG gentamicin and Piperacillin- tazobactam
- DRUG standard of care antibiotics and metronidazole
- DRUG metronidazole, clindamycin, or piperacillin-tazobactam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-04-20 |
| Phase | Phase 2 |
What the finished NCT01994993 record still lists
NCT01994993 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% higher).
The record links to 0 conditions, and to 5 interventions - of which ampicillin and metronidazole and gentamicin is the first listed.
NCT01994993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01994993 about?
NCT01994993 is a clinical study titled "Antibiotic Safety (SCAMP)". The main purpose of this study is evaluate whether it is safe or not to use various combination of antibiotics (ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, gentamicin) in treating infants with complicated intra-abdominal infections
What is the current status of trial NCT01994993?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 260 participants. The study started on 2013-12. Estimated completion is 2017-04-20.
What interventions are being tested in trial NCT01994993?
The interventions under investigation include: ampicillin and metronidazole and gentamicin (DRUG), ampicillin and gentamicin and clindamycin (DRUG), gentamicin and Piperacillin- tazobactam (DRUG), standard of care antibiotics and metronidazole (DRUG), metronidazole, clindamycin, or piperacillin-tazobactam (DRUG).
Who is sponsoring clinical trial NCT01994993?
This trial is sponsored by Michael Cohen-Wolkowiez, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01994993's enrollment target sits among peer trials
260 210th of 2000 higher than 1,789 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia